REGENEXA PEPTIDE LIBRARY

Every peptide, every vial, one page.

Click any peptide to expand full research, dosing and safety details — no page changes, no extra clicks.

Prefer to just ask? Chat with Regenexa AI →

The Regenexa Library, organized by what you're researching.

Explore by topic

RECENTLY APPROVED THERAPIES

Compounds with a specific, cited regulatory approval.

Each entry below lists the exact authority, approved indication and jurisdiction — regulatory status varies by country. This is not a claim that every Regenexa product presentation is approved, that the approval covers off-label or research use, or that the compound is approved in Lebanon or the UAE.

Muscle Growth & Performance

Tesamorelin

U.S. FDA — approved for Reduction of excess visceral abdominal fat in adults with HIV-associated lipodystrophy (United States (FDA), as Egrifta / Egrifta SV / Egrifta WR).

The approval is specific to this one indication and population — it does not cover general body-composition, anti-aging or performance use, which is off-label, and is not a statement that Regenexa's research-use tesamorelin product is itself an approved medicine.

Source: FDA drug label — EGRIFTA (tesamorelin for injection) · verified 2026-07-26

Hormonal & Sexual Wellness

Oxytocin

U.S. FDA — approved for Intravenous/intramuscular use for labor induction or augmentation, and control of postpartum uterine bleeding (United States (FDA), as Pitocin (and generic oxytocin injection)).

This approval covers only supervised IV/IM obstetric use. It does not cover intranasal or subcutaneous use for social-bonding, anxiolytic or other behavioral-research purposes — that is a separate, unapproved context — and is not a statement that Regenexa's research-use oxytocin product is itself an approved medicine.

Source: FDA drug label — Pitocin (oxytocin injection, USP) · verified 2026-07-26

Hormonal & Sexual Wellness

PT-141

U.S. FDA — approved for Acquired, generalized hypoactive sexual desire disorder (HSDD) in PREMENOPAUSAL women specifically (United States (FDA), as Vyleesi (bremelanotide)).

The approval is limited to this one condition and population — it does not cover use in men, in postmenopausal women, or via intranasal/other unapproved routes, all of which are off-label, and is not a statement that Regenexa's research-use PT-141 product is itself an approved medicine.

Source: FDA drug label — Vyleesi (bremelanotide) injection · verified 2026-07-26

Bundles →

Metabolic & Weight Management

Retatrutide

Triple GIP/GLP-1/glucagon receptor agonist studied in human clinical trials for metabolic and weight research.

5 mg10 mg20 mg30 mg40 mg

Available following assessment

Appetite and metabolic-rate researchCardiometabolic marker studiesBody-composition research

Metabolic & Weight Management

Cagrilintide

Amylin-receptor agonist studied for appetite regulation, often alongside GLP-1 agonists in combination research.

5 mg

Available following assessment

Appetite-regulation researchAmylin-pathway studiesCombination metabolic research

Metabolic & Weight Management

CagriSema

Combination cagrilintide/semaglutide studied for dual amylin and GLP-1 receptor signaling in weight research.

5 mg10 mg

Available following assessment

Dual-pathway appetite researchWeight-management studiesMetabolic marker research

Skin, Beauty & Anti-Aging

SNAP-8

Acetyl octapeptide studied topically for expression-line and neuromuscular signaling research in skin.

10 mg

Available following assessment

Expression-line researchTopical anti-aging studies

Metabolic & Weight Management

Survodutide

GLP-1/glucagon dual receptor agonist studied for weight management and liver-fat research.

5 mg

Available following assessment

Weight-management researchLiver-fat marker studiesMetabolic research

Metabolic & Weight Management

Mazdutide

GLP-1/glucagon dual receptor agonist studied primarily in Chinese clinical trials for weight and metabolic research.

5 mg

Available following assessment

Weight-management researchMetabolic marker studies

Metabolic & Weight Management

AOD-9604

Modified fragment of human growth hormone (176-191) studied for fat-metabolism research without GH growth effects.

5 mg

Available following assessment

Lipolysis researchFat-metabolism studies

Longevity & Healthy Aging

NAD+

Coenzyme studied for cellular-energy metabolism, DNA-repair signaling and aging-biology research.

100 mg500 mg

Available following assessment

Cellular-energy researchDNA-repair pathway studiesAging-biology research

Energy & Mitochondrial Support

MOTS-C

Mitochondrial-derived signaling studied in metabolic adaptation and cellular stress.

10 mg50 mg

Available following assessment

Exercise-adaptation researchMetabolic-flexibility studiesCellular-stress-response research

Metabolic & Weight Management

5-Amino-1MQ

Small-molecule NNMT inhibitor studied for fat-metabolism and cellular-energy research.

5 mg

Available following assessment

Fat-metabolism researchNNMT-pathway studies

Longevity & Healthy Aging

Epitalon

Experimental peptide bioregulator investigated in aging-related cellular pathways.

10 mg50 mg

Available following assessment

Cellular-aging researchCircadian and sleep-pattern studiesEndocrine-signaling research

Skin, Beauty & Anti-Aging

GHK-Cu

Copper-binding peptide studied in extracellular-matrix and tissue-remodeling pathways.

50 mg100 mg

Available following assessment

Skin-remodeling researchWound and matrix-repair studiesHair-follicle research

Skin, Beauty & Anti-Aging

GLOW

Blended skin-and-repair peptide product (commonly GHK-Cu with repair peptides); exact composition varies by batch.

70 mg

Available following assessment

Combined skin-repair researchMatrix and tissue synergy studies

Skin, Beauty & Anti-Aging

KLOW

Blended multi-peptide skin-and-repair product (commonly GHK-Cu, BPC-157, TB-500 and Kisspeptin); exact composition varies by batch.

80 mg

Available following assessment

Combined skin-repair researchMulti-pathway synergy studies

Skin, Beauty & Anti-Aging

Melanotan I

Melanocortin-1 receptor agonist studied for melanogenesis and photoprotection research.

10 mg

Available following assessment

Pigmentation researchPhotoprotection studies

Hormonal & Sexual Wellness

Melanotan II

Broader melanocortin-receptor agonist studied for pigmentation and libido-related research.

10 mg

Available following assessment

Pigmentation researchLibido-related studies

Hormonal & Sexual Wellness

Kisspeptin

GnRH-signaling neuropeptide studied for reproductive hormone regulation, largely in fertility-research contexts.

5 mg

Available following assessment

Reproductive-hormone researchFertility-signaling studies

Cognitive & Neurological Support

Adamax

Blended nootropic peptide product studied for cognitive and mood-related research; exact composition varies by supplier.

10 mg

Available following assessment

Cognitive-performance researchMood-related studies

Cognitive & Neurological Support

Selank+Semax Blend

Combination of two Russian-origin peptides studied for anxiolytic and nootropic effects.

10 mg

Available following assessment

Anxiolytic researchCognitive-performance studies

Cognitive & Neurological Support

Semax

ACTH-fragment analog studied in Russian research literature for cognitive and neuroprotective effects.

11 mg

Available following assessment

Cognitive researchNeuroprotection studies

Sleep & Stress Management

Selank

Tuftsin analog studied for anxiolytic and immune-modulating effects, mainly in Russian research literature.

11 mg

Available following assessment

Anxiolytic researchImmune-modulation studies

Sleep & Stress Management

DSIP

Delta sleep-inducing peptide studied for potential effects on sleep regulation and stress response.

5 mg

Available following assessment

Sleep-regulation researchStress-response studies

Hormonal & Sexual Wellness

Oxytocin

Neuropeptide hormone studied for social bonding, trust and some anxiolytic/metabolic research angles.

5 mg

Available following assessment

Social-bonding researchAnxiolytic-adjacent studies

Regeneration & Recovery

BPC-157 + TB-500

Combination repair peptide blend studied for tissue-response, vascular-signaling and cell-migration research.

20 mg

Available following assessment

Combined tissue-repair researchRecovery and mobility studies

Regeneration & Recovery

BPC-157

Preclinical investigation of tissue response, vascular signaling and repair pathways.

5 mg10 mg

Available following assessment

Tissue-repair researchTendon and ligament studiesGastrointestinal research

Regeneration & Recovery

TB-500

Research associated with thymosin-beta-4-related cell migration and repair signaling.

5 mg10 mg

Available following assessment

Cell-migration researchRecovery and mobility studiesAngiogenesis research

Energy & Mitochondrial Support

SS-31

Mitochondria-targeted peptide studied in membrane energetics and oxidative stress.

10 mg

Available following assessment

Mitochondrial-membrane researchOxidative-stress studiesEnergy-metabolism research

Immune Support

Thymosin Alpha-1

Immune-modulating peptide studied in infectious-disease and oncology-adjunct research contexts.

10 mg

Available following assessment

Immune-modulation researchInfection-response studies

Immune Support

Glutathione

Master antioxidant tripeptide studied for oxidative-stress, detoxification and skin-brightening research.

500 mg

Available following assessment

Antioxidant researchDetoxification-pathway studiesSkin-brightening research

Immune Support

KPV

C-terminal alpha-MSH fragment studied for anti-inflammatory and gut-healing research without pigmentation effects.

10 mg

Available following assessment

Anti-inflammatory researchGut-healing studies

Hormonal & Sexual Wellness

PT-141

Melanocortin-receptor agonist (bremelanotide) studied for sexual arousal disorders; one formulation is FDA-approved for a specific indication.

10 mg

Available following assessment

Sexual-arousal researchMelanocortin-pathway studies

Muscle Growth & Performance

CJC no-DAC / Ipamorelin

Combination GHRH analog and ghrelin-receptor agonist studied for growth-hormone pulse research.

10 mg

Available following assessment

Growth-hormone pulse researchRecovery and sleep-quality studies

Muscle Growth & Performance

Tesamorelin

GHRH analog studied for GH-axis research; one formulation is FDA-approved for HIV-associated lipodystrophy.

5 mg10 mg

Available following assessment

GH-axis researchBody-composition studies

Muscle Growth & Performance

IGF-1 LR3

Long-arginine3 IGF-1 analog studied for anabolic and growth-factor signaling research.

0.1 mg1 mg

Available following assessment

Anabolic-signaling researchGrowth-factor studies

Muscle Growth & Performance

Ipamorelin

Selective ghrelin-receptor agonist studied for GH release with a comparatively mild side-effect profile.

5 mg10 mg

Available following assessment

Growth-hormone release researchRecovery studies

Muscle Growth & Performance

CJC-1295 With DAC

GHRH analog with drug-affinity complex studied for extended-duration growth-hormone pulse research.

5 mg

Available following assessment

Growth-hormone pulse researchBody-composition studies

Muscle Growth & Performance

CJC-1295 No DAC

Shorter-acting GHRH analog variant studied for growth-hormone pulse research.

5 mg

Available following assessment

Growth-hormone pulse researchRecovery studies

Muscle Growth & Performance

Sermorelin

GHRH(1-29) analog historically studied diagnostically and therapeutically for GH-stimulation research.

5 mg10 mg

Available following assessment

GH-stimulation researchEndocrine-testing studies

Muscle Growth & Performance

GHRP-2

Ghrelin-receptor agonist and growth-hormone secretagogue studied for GH-release research.

5 mg

Available following assessment

Growth-hormone release researchAppetite-related studies

Muscle Growth & Performance

GHRP-6

Ghrelin-receptor agonist studied for growth-hormone release and appetite-stimulation research.

5 mg

Available following assessment

Growth-hormone release researchAppetite-stimulation studies

Accessories

Bacteriostatic Water

Sterile, USP-grade water preserved with 0.9% benzyl alcohol, used to reconstitute lyophilized (freeze-dried) peptides. This is a diluent, not an active peptide.

10 mL

Sterility testedPreserved for repeated multi-dose useStandard reconstitution volume for most vials

GLOBAL RESEARCH GATEWAYS

Primary registries and regulatory sources.

USA · ClinicalTrials.gov

Live registry of registered human studies

Open source ↗USA · PubMed

Biomedical literature indexed by the U.S. National Library of Medicine

Open source ↗USA · FDA

Safety risks for selected substances used in compounding

Open source ↗UK · MHRA

Current public guidance and safety updates for GLP-1 medicines

Open source ↗UK · NICE

UK clinical-guidance and evidence-appraisal body

Open source ↗Europe · EU CTR

European Union clinical trial search

Open source ↗Europe · EMA

European Medicines Agency safety and approval data

Open source ↗China · ChiCTR

Chinese Clinical Trial Registry

Open source ↗Russia · PubMed index

Internationally indexed Russian peptide-bioregulator literature

Open source ↗Global · WHO ICTRP

International clinical-trial search portal

Open source ↗Global · Cochrane Library

Systematic reviews and meta-analyses

Open source ↗

The library is curated, not an exhaustive reproduction of every publication. Regulatory status and evidence can change; local licensed review is required.